Bluebird Bio Inc (BLUE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

60 BINNEY STREET CAMBRIDGE, MA 02142

Bluebird Bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases.

Data as of 2020-05-30
Market Cap3.541 Billion Shares Outstanding55.652 Million Avg 30-day Volume1.817 Million
P/E Ratio Dividend Yield EPS-14.96
Price/Sales65.497 Price cash flow ratio5.7 Price free cash flow ratio-4.9
Book Value20.13 Price to Tangible Book3.09 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.308703
BETA2.36037 52-week High/Low143.98 / 38.95 Stddev0.181308

Are you looking for these stocks instead?

View SEC Filings from BLUE instead.

View recent insider trading info

Funds Holding BLUE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLUE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

815 total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DIXON WENDY L

  • Director
14,061 2020-05-26 1

LYNCH DANIEL

  • Director
  • 10% Owner
0 2020-05-20 1

MARAGANORE JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
200,722 2020-05-20 0

BAIRD WILLIAM D III

  • Director
0 2020-05-20 2

HEDLEY MARY LYNNE

  • Director
1,022 2020-05-16 0

TEPPER ROBERT I

  • Director
  • 10% Owner
0 2020-05-06 0

DAVIDSON DAVID CHIEF MEDICAL OFFICER

39,934 2020-05-01 7

LESCHLY NICK PRESIDENT AND CEO

269,490 2020-05-01 3

COLE JASON CHIEF OPERATING AND

  • LEGAL OFFICER
35,486 2020-05-01 3

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

36,219 2020-05-01 14

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

27,204 2020-05-01 4

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

22,594 2020-05-01 5

GILLIS STEVEN

  • Director
0 2020-04-02 0

AGWUNOBI JOHN O CEO

  • Officer
39,273 2020-03-30 1

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

10,344 2020-03-02 5

SCHENKEIN DAVID P

  • Director
454,907 2020-02-22 1

SELLERS WILLIAM R.

  • Director
2,000 2019-09-25 2

WALSH JEFFREY T. CHIEF STRATEGY OFFICER

  • Officer
40,921 2019-08-20 3

FINER MITCHELL H.

  • Director
0 2019-07-31 0

ARCH VENTURE FUND VII, L.P.

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • 10% Owner
4,242,051 2019-07-15 0

VACHON MARK

  • Director
2,000 2019-06-06 1

MELTON DOUGLAS

  • Director
4,700 2019-06-06 1

HIGH SUSANNA GATTI CHIEF OPERATING OFFICER

  • Officer
13,735 2018-12-06 0

MANDELL JAMES

  • Director
1,000 2018-09-10 0

SULLIVAN ERIC PRINCIPAL ACCOUNTING OFFICER

  • Officer
5,974 2017-08-03 0

DETORE JAMES M. SEE REMARKS

  • Officer
0 2016-08-04 0

BAIN LINDA CHIEF FINANCIAL OFFICER

  • Officer
41,930 2015-08-21 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-04-07 0

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

TVM CAPITAL GMBH

POLACK AXEL

SCHUHSLER HELMUT

GOLL ALEXANDRA

BIRNER HUBERT

FISCHER STEFAN

  • 10% Owner
2,254,357 2013-06-24 0

MULDER GEERT-JAN

  • Director
No longer subject to file 2013-06-24 0

POLACK AXEL

  • Director
2,254,357 2013-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-05-04 S 45 $50.81 d 22,609 22,594.00 direct

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-05-04 S 172 $49.88 d 22,654 22,594.00 direct

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-05-04 S 15 $51.57 d 22,594 22,594.00 direct

LESCHLY NICK PRESIDENT AND CEO

2020-05-01 A 11,384 a 100,791 269,490.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-05-01 A 1,511 a 36,219 36,219.00 direct

DAVIDSON DAVID CHIEF MEDICAL OFFICER

2020-05-01 A 1,615 a 39,934 39,934.00 direct

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

2020-05-01 A 1,361 a 27,204 27,204.00 direct

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-05-01 A 1,433 a 22,826 22,594.00 direct

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2020-05-01 A 1,437 a 35,486 35,486.00 direct

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-04-06 S 583 $43.73 d 21,393 21,393.00 direct

Elevate your investments